Tags : Merger Agreement

M&A

Roche to Acquire GenMark Diagnostics for $1.8B

Shots: Roche to acquire all outstanding shares of GenMark’s for $24.05/ share in cash, making a total deal value of $1.8B with a premium of ~43% to GenMark’s closing price on Feb 10, 2021. The acquisition is expected to be completed in Q2’21 The acquisition will boost Roche’s molecular diagnostics portfolio and will expand the […]Read More